The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran

Background: Vulvovaginal candidiasis (VVC) is a prevalent infectious disease that affects the majority of women. While Candida albicans is the most common cause of VVC, the prevalence of non-albicans species is increasing, and mixed infections have made treatment more challenging. This study aimed t...

Full description

Bibliographic Details
Published in:	Clinical and Experimental Obstetrics & Gynecology
Main Authors:	Batoul Jannati, Arash Pourdad, Ali Izadjoo, Hossein Zarrinfar, Mohammad Javad Najafzadeh, Abdolmajid Fata
Format:	Article
Language:	English
Published:	IMR Press 2024-03-01
Subjects:	vulvovaginal candidiasis non-albicans candida women iran
Online Access:	https://www.imrpress.com/journal/CEOG/51/3/10.31083/j.ceog5103077

Similar Items

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
by: Jian Miao, et al.
Published: (2023-04-01)

In vitro photodynamic therapy of Candida albicans, the cause of vulvovaginal candidiasis, is enhanced by Bacillus and Enterococcus probiotics
by: Zeinab Ghanbari, et al.
Published: (2025-02-01)

Characterization of ERG11 Gene in Drug-Resistant Candida Albicans Isolated from Iranian Cases of Recurrent Vulvovaginal Candidiasis
by: Kambiz Diba, et al.
Published: (2020-06-01)

Distribution of Candida albicans and Non-albicans Candida Species Causing Vaginitis in Iran: A Review
by: OmeFarveh Rostami, et al.
Published: (2025-04-01)

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis
by: Mei Gao, et al.
Published: (2016-11-01)

Prevalence of Closely Related Candida albicans Species among Patients with Vulvovaginal Candidiasis in Southern Poland Based on the hwp1 Gene Amplification
by: KLESIEWICZ KAROLINA, et al.
Published: (2023-03-01)

Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method
by: Baghdad Science Journal
Published: (2016-06-01)

A Comprehensive Overview of <i>Candida albicans</i> as the Leading Pathogen in Vulvovaginal Candidiasis
by: Nika Srb, et al.
Published: (2025-08-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Synergistic Inhibition of <i>Candida albicans</i> by Cranberry Proanthocyanidins and Probiotics: Novel Strategies for Vulvovaginal Candidiasis Treatment
by: Yu-Ru Wu, et al.
Published: (2025-03-01)

Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
by: Gerges MA, et al.
Published: (2023-08-01)

Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis
by: N. D. Yakovychuk, et al.
Published: (2017-06-01)

Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis
by: Jingyun Zhang, et al.
Published: (2022-05-01)

The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis
by: Li L, et al.
Published: (2024-10-01)

Synergistic Antifungal Effect of Fluconazole Combined with ZnO Nanoparticles against Candida albicans Strains from Vaginal Candidiasis
by: Azadeh abedzadeh hajar, et al.
Published: (2020-05-01)

A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains
by: Arianna Sala, et al.
Published: (2023-04-01)

Genotypic Patterns of Secreted Aspartyl Proteinase Gene in Various Candida Species Isolated from Antenatal Women with Vulvovaginal Candidiasis
by: Kanishka Hrishi Das, et al.
Published: (2019-06-01)

Study on the impact of biofilm formation by Candida albicans in recurrent vulvovaginal candidiasis on drug susceptibility
by: Sainan Li, et al.
Published: (2025-09-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Treatment of vulvovaginal candidiasis in preparation programs for in vitro fertilization
by: A. Yu. Romanov, et al.
Published: (2021-10-01)

Candida species causing vulvovaginitis among patients in Babcock University Teaching Hospital, Ilishan-Remo, Ogun State: A retrospective cross-sectional study
by: Tinuade Adesola Ajani, et al.
Published: (2024-01-01)

Molecular biological characteristics of Candida albicans strains causing recurrent vulvovaginal candidiasis with different susceptibility to antifungal drugs in vitro
by: Venchakova V.V., et al.
Published: (2025-03-01)

In Vitro Evaluation of Corn Silk Extract as a Potential Alternative Therapy for Vulvovaginal Candidiasis
by: Liberty P., et al.
Published: (2023-12-01)

Species Distribution, Characterization, and Antifungal Susceptibility Patterns of <i>Candida</i> Isolates Causing Oral and Vulvovaginal Candidiasis in Chile
by: Francisca Nahuelcura, et al.
Published: (2025-07-01)

Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: A meta-analysis of randomized controlled trials
by: Rong He, et al.
Published: (2024-04-01)

Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates
by: Sayanika Devi Waikhom, et al.
Published: (2020-05-01)

Resistant C. albicans implicated in recurrent vulvovaginal candidiasis (RVVC) among women in a tertiary healthcare facility in Kumasi, Ghana
by: Abena Kyeraa Sarpong, et al.
Published: (2024-07-01)

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
by: V. N. Serov, et al.
Published: (2016-12-01)

Clinical Candida albicans Vaginal Isolates and a Laboratory Strain Show Divergent Behaviors during Macrophage Interactions
by: Franziska Gerwien, et al.
Published: (2020-08-01)

Vapor phase of white thyme essential oil: effect on Candida albicans and preservation of Lactobacillus species in the context of vulvovaginal candidiasis
by: Liliana Fernandes, et al.
Published: (2025-10-01)

Determination of Drug Susceptibility of Candida Strains Isolated From Patients With Recurrent Candida Vulvovaginitis and Investigation of Predisposing Factors of the Disease
by: MH Minooeianhaghighi, et al.
Published: (2017-03-01)

Vaginal Candidiasis among Pregnant Women in Ebonyi State, South East Nigeria.
by: Chito Clare Ekwealor, et al.
Published: (2023-09-01)

Prevalence and Changing Virulence Factors and Biofilm Formation among Non-Albicans Candida Species in Suspected Vulvovaginitis Infections
by: Rahul Gopichand Walide1*, et al.
Published: (2024-12-01)

Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
by: Humberto Fabio Boatto, et al.
Published: (2016-06-01)

pH-Dependant Antifungal Activity of Valproic Acid against the Human Fungal Pathogen Candida albicans
by: Julien Chaillot, et al.
Published: (2017-10-01)

Comparison of Fluconazole and Clotrimazole in the Treatment of Acute Candida Albicans Vulvovaginitis
by: Fatemeh Bahadori, et al.
Published: (2008-12-01)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
by: Narges Aslani, et al.
Published: (2021-12-01)

Dual Mechanisms of Action: Anti-Candida and Anti-Inflammatory Potential of <i>Lactobacillus</i> Fermentation Broth in Treating Vulvovaginal Candidiasis
by: Huann-Cheng Horng, et al.
Published: (2024-12-01)

Comparison between Conventional Methods and Molecular Diagnosis for Candida albicans and Candida dubliniensis isolated from Cancer Patients Infected with Oral Candidiasis
by: Nada Fadhil Abbas
Published: (2024-10-01)

The Validity of Point-of-Care Test (POCT) Lateral Flow Immunochromatographic Assay (LFIA) Candida albicans for the Diagnosis of Vulvovaginal Candidiasis
by: Monika Puspitasari, et al.
Published: (2024-07-01)